4//SEC Filing
Buckland Andrew J 4
Accession 0001079973-09-000528
CIK 0001006028other
Filed
May 17, 8:00 PM ET
Accepted
May 18, 7:06 PM ET
Size
5.8 KB
Accession
0001079973-09-000528
Insider Transaction Report
Form 4
PURE BIOSCIENCEPURE
Buckland Andrew J
Chief Financial Officer
Transactions
- Award
Stock Option
2009-05-14+80,000→ 80,000 totalExercise: $2.34From: 2010-05-14Exp: 2014-05-14→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]Granted pursuant to Pure Bioscience 2007 Equity Compenstion Plan. One-quarter of the options vest each year for four years following the date of grant.
Documents
Issuer
PURE BIOSCIENCE
CIK 0001006028
Entity typeother
Related Parties
1- filerCIK 0001332290
Filing Metadata
- Form type
- 4
- Filed
- May 17, 8:00 PM ET
- Accepted
- May 18, 7:06 PM ET
- Size
- 5.8 KB